Oncology How automating flow cytometry is revolutionising cancer diag... As the incidence of cancer rises around the world, the demand for faster, more precise diagnoses is also on the rise.
Oncology ASCO 2024: Emphasising the art and science behind enhanced c... The term “practice-changing” is often used when scientific advances promise to shift traditional treatment paradigms.
Oncology Sponsored Clinical decision-making insights for haem/oncs Despite the effects of countries’ lockdown policies, a plethora of clinical trial readouts continue to emerge providing several decision-making challenges for healthcare professionals.
Partner Content Partner Content When science and biology combine – the outlook for ADCs in c... Antibody Drug Conjugates (ADCs) are treatments formed by the conjugation of monoclonal antibodies and cytotoxic agents.
News NHS starts first national rollout of Blenrep for myeloma England is the first country in the world to make GSK's relaunched anti-BCMA drug Blenrep available to patients with multiple myeloma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
